A series of novel 5-Bromo-3-iodo-1H-pyrazolo [3,4-b]pyridine linked various sulfonamide derivatives 8a-8j poly functionalized were designed and synthesized in moderate to good yield. A starting with iodination of 5-Bromo-1H-pyrazolo [3,4-b]pyridine 5 with iodine produced intermediate 5-Bromo-3-iodo-1H-pyrazolo [3,4-b]pyridine 6 with the reaction of various sulfonamide derivatives 7a-7j via copper catalyzed coupling reaction produced targeted compounds8a-8j. The isolated compounds were accepted by spectral and elemental analysis. The compounds 8a,8c,8d, and 8i were excellent active against Gram-positive and gram-negative bacterial strain compare to streptomycin standard drug. All synthesized compounds showed moderate to good antioxidant properties with used DPPH and Superoxide radical scavenging assay, Compounds 8c, 8g, and 8i exerted significant antioxidant scavenging activity for the DPPH radical.
Introduction
Mainly medicinal scientist has drawn the awareness to discover and rapid development of N, S and O containing versatile heterocyclic entities because of their natural and synthetic occurrence, efficacious activities and biological evolution. [1] [2] Due to the first drug used as a preventive and chemotherapeutic agent and also the wide range of pharmacological applicability of sulfonamide (sulfa drugs), the researcher has been widely studied RSO2NH2 functionality containing compounds. 3-,4 This functionality has an extensive verity of biological activities as Antibacterial and Antifungal activity [5] [6] , Carbonic anhydrase inhibitors (CAIs) [7] [8] , Anti cancer 9 Anti HIV [10] [11] , Cyclooxygenase-2 (COX-2) inhibitors 12 , Anti malarial 13 , type-II diabetes 14 , treating male erectile dysfunction 15 , etc.
Another hand, The fused small synthesized heterocycles such as pyrazole work as potent pharmacophores such as celecoxib 1 sildenafil citrate 2 in figure-1 having sub structural popular drug. [16] [17] In addition, hetreobiaryle pyrazolopyridine (1H-pyrazolo [3,4-b] pyridine) considerable important in the group of fused heterocycles which has shown the most powerful therapeutic activity. Pyrazolo [3,4-b] pyridine show large numbers of significant biological properties such as antimicrobial 18 , antiviral 19 , antitumer 18 , analgesic 20 , anti inflammatory 21 , cyclooxygenase-(COX) inhibitors 21 , selective c-Met inhibitors 22 , selective Raf inhibitors 23 , antioxidant activities 24 , etc.
It is a well-known literature study of Pyrazolo [3,4-b] pyridine combine with sulfonamides has been found an exhibit diverse range of therapeutic activities. Compound 3 reported by chandak et al. showed good antibacterial and antifungal activities 25 [3,4-b] pyridin-3-yl)amino)-N-(substituted)benzenesulfonamide 8a-8j by consequent procedure were characterized by elemental analysis, spectral data and examine by well-recognized pharmacophore with different range of activity such as antibacterial activity against gram +ve and gram -ve strains with minimum inhibition concentration (MIC) and also antioxidant assay with DPPH radical scavenging activity assay and Superoxide radical scavenging assay. 
Results and Discussion

Chemistry
Our initial endeavour in this work was developed well potent chemotherapeutic agent. The key intermediate 5-Bromo-3-iodo-1H-pyrazolo[3,4-b]pyridine 6 were prepared by iodination with iodine of 5-Bromo-3-iodo-1H-pyrazolo [3,4-b] pyridine 5 with good yield (Scheme-1). Further, the compound 6 was effectively coupling with a various sulfonamide (Sulfa drugs) 7a-7j using copper iodide and potassium carbonate as a catalyst in the presence of isopropyl alcohol produced targeted compounds 8a-8j with good yield. Identification of structural 4-((5-bromo-1H-pyrazolo [3,4-b] pyridin-3-yl)amino)-N-(various substitution)benzenesulfonamide 8a-8j were characterized by IR, 1 H NMR, In 1 H NMR (400 MHz, DMSO) of intermediate 6 were showed singlet for two pyridine ring proton (Py-H) at δ 8.21, 8.65 ppm and the signal of -NH display at 14.32 ppm. For 8a-8j the phenyl ring hydrogen (Ar-H) of sulfonamide peak appear doublet in the region δ 6.8 ppm to 8.1 ppm. As expected, the singlet of -NH hydrogen for sulfonamide shows different range ~11 ppm while, singlet of pyrazole appear in the range ~14 ppm.
The infrared spectrum of all compounds showed stretching band ~3400 cm -1 and ~3200 cm -1 for sulfa -NH and pyrazolo-NH. The absence of symmetric and asymmetric band of -NH2 indicate that sulfa drugs and pyrazolo [3,4-b] The significant results shown for all synthesized new series of 8a-8j were excellent, good and average active against Gram-positive and gram-negative bacteria. On the bases of this results, we bring to a close that zone inhibition of the antibacterial activity of some synthesized compounds could be increased such as 8a, 8c, 8d and 8i, while the other compounds were decreased antibacterial compared to standard, shown in Table 1 . 
Fig. 2. Zone inhibition antibacterial activity of compounds 8a-8j
The MIC values of these 8a-8j series showed significant results For all synthesized compounds the 8a, 8c, 8d, 8h and 8i scaffold showed very good MIC values near to streptomycin shown in table-2 and another compound has shown average MIC values. However, the compound 8a and 8c showed very good zone inhibition activity as well as in MIC for all bacterial strains. 
Antioxidant activity
2,2'-diphenyl-1-picrylhydrazyl (DPPH) assay used for in vitro free radical scavenging activity of all the synthesized compounds 8a-8j, As reported method 26 shown in table-3. All synthesized compounds showed antioxidant properties which calculated by percentage (%) Inhibition and also dependent on scavenging radical.
The higher value of concentration indicated the increased value of the scavenging activity of the DPPH radical. 8a, 8c, 8g, 8i and 8j all compounds have shown very good radical scavenging activity. However, scaffold 8i (38.10-81.15 µg/ml) displayed more efficient scavenging activity in all three concentration range while compounds 8c showed steady activity and compound 8g (82.15 µg/ml) showed excellent actively at higher concentration (600µg/ml). And the other derivatives showed an average reduction of DPPH scavenging activity. According to reported method. [26] [27] The free radical scavenging activity of all the synthesized compounds 8a-8j were screened by Superoxide anion system. phenezine methosulfate -nicotinamide adenine dinucleotide (PMS-NADH) system was used for evolved superoxide anion which tested by the reduction of nitroblue tetrazolium (NBT). Superoxide anion scavenging was assayed at different concentration 0.00 µg/ml, 200 µg/ml, 400 µg/ml and 600 µg/ml and calculated for IC50 value for all compounds which mentioned in Table- 4. All compounds showed considerable results, however, the values correspond to 8i showed excellent in both DPPH radical scavenging (38.10-81.15 µg/ml) and Superoxide anion scavenging (37.43-83.24 µg/ml) antioxidant activity. The other compounds relatively displayed average superoxide anion scavenging activity. 
Conclusions
In this present work we explain the synthesis and characterization of 4-((5-bromo-1H-pyrazolo[3,4-b]pyridin-3-yl)amino)-N-(substituted)benzenesulfonamide 8a-8j and evaluated for their in vitro antibacterial against two Gram-positive and two gram-negative strains, for the tested results 8a, 8c, 8d and 8i, derivatives found to have most potent antibacterial. Moreover, the derivatives of 8a, 8c, 8g, 8i and 8j appeared as good inhibition for DPPH radical scavenging antioxidant activity but compound 8i being a most powerful antioxidant in both strain DPPH radical scavenging (38.10-81.15 µg/ml) and Superoxide anion scavenging (37.43-83.24 µg/ml).
Experimental
Materials and Methods
Chemical and reagents were used all sulfa drugs and 5-Bromo-1H-pyrazolo[3,4-b]pyridine were acquired from commercial sources (Sigma-Aldrich). and iodine (I2), Potassium hydroxide (KOH), dimethylformamide, (DMF), Isopropyl alcohol, Cuprous iodide (CuI), and Ethylene glycol from Merck (Germany). Pre-coated aluminium sheets (silica gel 60 F254, Merck) were used for thin-layer chromatography (TLC) and spots were visualized under ultraviolet light. Melting point (M.P) were measured by using a Mel-temp instrument, and results are uncorrected. Infra-red spectra were recorded on Shimadzu spectrophotometer in the frequency range 4000-400 cm -1 using KBr pallet disc, 1 H NMR and 13 C NMR spectra were recorded on Bruker at 400 MHz and 100 MHz in DMSO solution and chemical shifts were recorded in parts per million (ppm) with TMS at the internal reference. Advion expression CMS, USA were used for recorded mass spectra. The compound was analyzed for Carbon, Hydrogen, Nitrogen oxygen and Sulpher was estimated on CHNS analyzer serial NO. : 15084053
General procedure 4.2.1 synthesis of 5-Bromo-3-iodo-1H-pyrazolo[3,4-b]pyridine 6 Prepared by earlier reported method by Na Liu et al.
28 
synthesis of 4-((5-bromo-1H-pyrazolo[3,4-b]pyridin-3-yl)amino)-N-(substituted)benzenesulfonamide 8a-8j
Dissolve compound 5-Bromo-3-iodo-1H-pyrazolo[3,4-b]pyridine 6 (3.6g 8.1 mmol) in i-PrOH (isopropanol, 50 mL) and added different sulfa drugs 7a-7j (1.9 g 9.7 mmol) , potassium carbonate (K2CO3,16.2 mmol), Cuprous iodide (CuI 8.1 mmol) and 16.2 mmol ethylene glycol then starred for 6 hours at 100 ºC under inert atmosphere with N2 at then cooled the mixture filtrated and washed with EtOH (80 mL) extracted organic layer and washed with ammonia water and brine (50 mL × 2). the layer of organic was dried over with using MgSO4 and concentrated to give Pyrazolo sulfonamides derivatives 8a-8j white to yellow solid. (70% yielded) [3,4-b] 
Physical and Spectral Data
4-((5-bromo-1H-pyrazolo[3,4-b]pyridin-3-yl)amino)-N-(2,3-dihydrothiazol-2-yl)benzenesulfonamide 8a
4-((5-bromo-1H-pyrazolo[3,4-b]pyridin-3-yl)aminobenzene-sulfonamide 8b
4-((5-bromo-1H-pyrazolo[3,4-b]pyridin-3-yl)amino)-N-(pyrimidin-2-yl)benzenesulfonamide 8d
4-((5-bromo-1H-pyrazolo
4-((5-bromo-1H-pyrazolo[3,4-b]pyridin-3-yl)amino)-N-(4-methoxypyridazin-2-yl)benzenesulfonamide 8g
